Archive | Melanoma In The News

Andtbacka Discusses Long-Term Data and Next Steps With T-VEC in Melanoma

Talimogene laherparapvec (T-VEC; Imlygic) continues to demonstrate durable response rates in patients with unresectable stage IIIb, IIIc, and IVM1a melanoma, according to long-term follow-up results from the pivotal phase III OPTiM study.

Read the full story

Posted in Melanoma In The News

New international research project identifies subtypes of ocular melanoma

A new international research project, involving the University of Liverpool’s leading eye cancer research group, has identified specific subtypes of ocular melanoma that will help develop improved management strategies and therapies in the future.

Read the full story

Posted in Melanoma In The News, Information

Endometriosis Linked to Higher Risk of Melanoma, but Not Other Skin Cancers, Study Suggests

Women with a history of endometriosis may have an increased risk of developing melanoma, but no association was seen in other skin cancers, according to the results of a large prospective analysis.

Read the full story

Posted in Melanoma In The News

Long-Term T-VEC Results in Melanoma Provide Reassurance for Clinicians and Patients, Expert Says

According to long-term follow-up results from the pivotal phase III OPTiM study, talimogene laherparapvec (T-VEC; Imlygic) continues to demonstrate durable response rates in patients with unresectable stage IIIb, IIIc, and IVM1a melanoma.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories